Patients who have a stent implanted to open a blocked coronary artery face dual risks of developing blood clots and of having excessive bleeding in the months following the procedure. While routine ...

A step forward in de-escalating treatment The evolution of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) has been shaped by the continuous challenge of balancing ...

For prolonged antithrombotic treatment after percutaneous coronary intervention (PCI), clopidogrel monotherapy was more ...

Three months of dual antiplatelet therapy after PCI may safely balance thrombosis and bleeding risk in both patients with low ...

In a new study presented at the American College of Cardiology’s Annual Scientific Session (ACC.25), South Korean researchers report that for patients at high risk for bleeding following stent ...

including in-stent thrombosis or branch occlusion/stenosis (68). These findings suggest that ocular complications observed after FD coverage of the OphA may also be associated with the non-standard ...

P2Y 12 inhibitor‐based single antiplatelet therapy (SAPT) after drug‐eluting stent implantation reduces major bleeding without increasing the risk of major adverse cardiovascular and cerebral events ...

In 43% of patients, multiple prior stents were present at the site of the target lesion ... and 84% and 68% were still on dual antiplatelet therapy (DAPT), respectively. TLR was less frequent in the ...

Of all the patients with an indication to receive DAPT at baseline (prior to ICH onset), the majority (54.2%) received DAPT with aspirin plus ticagrelor. Overall, 20 patients (83.3%) received ...

De-escalating from aspirin plus ticagrelor to aspirin plus clopidogrel 1 month post-percutaneous coronary intervention (PCI) was associated with favorable outcomes in patients with stabilized ...